undefined undefined
NaN.000
NaN.00%
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-08 18:50
Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES, March 4, 2024 /PRNewswire/ -- Armata Ph...
03-05 05:01
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.31) by 177.42 percent. This is a 258.33 percent decrease over losses of $(0.24) per
2023-11-15 05:05
MARINA DEL REY, Calif., Sept. 21, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on pathogen-specific bacteriophage thera...
2023-09-21 19:00
What is the target price for Armata Pharmaceuticals (ARMP)?The latest price tar...
2023-08-14 11:09
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Monday. Following the market opening Monday, the Dow traded up 0.46% to 35,391.23 while the NASDAQ rose 0.33% to 14,079.09. The S&P 500, also rose, gaining, 0.43% to 4,555.71.
2023-07-24 22:45
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Rating) was the target of...
2023-03-30 10:23
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Rating) was the target of...
2023-03-30 10:23
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Rating) – Equities resear...
2023-03-20 13:44
Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Rating) is scheduled to be rele...
2023-03-14 20:12